Clarity Pharmaceuticals Ltd (ASX:CU6)
Australia · Delayed Price · Currency is AUD 3.600
+0.200 (5.88%)
At close: Mar 18, 2026
Clarity Pharmaceuticals Market Cap
Clarity Pharmaceuticals has a market cap or net worth of 1.27 billion as of March 18, 2026. Its market cap has increased by 28.29% in one year.
Market Cap
1.27B
Enterprise Value
1.04B
Revenue
10.58M
Ranking
n/a
PE Ratio
n/a
Stock Price
3.60
Market Cap Chart
Since August 25, 2021, Clarity Pharmaceuticals's market cap has increased from 384.20M to 1.27B, an increase of 229.43%. That is a compound annual growth rate of 29.87%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 17, 2026 | 1.27B | 0.65% |
| Dec 31, 2025 | 1.26B | -6.00% |
| Dec 31, 2024 | 1.34B | 168.49% |
| Dec 29, 2023 | 498.26M | 93.82% |
| Dec 30, 2022 | 257.07M | 35.63% |
| Dec 31, 2021 | 189.54M | -50.67% |
| Aug 25, 2021 | 384.20M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Telix Pharmaceuticals | 3.83B |
| Mesoblast | 2.72B |
| Neuren Pharmaceuticals | 1.49B |
| PYC Therapeutics | 1.39B |
| Opthea | 738.77M |
| Clinuvel Pharmaceuticals | 498.49M |
| Racura Oncology | 394.38M |
| Orthocell | 219.76M |